Antibodies against Malondialdehyde in Haemodialysis Patients and Its Association with Clinical Outcomes: Differences between Subclasses and Isotypes
Patients on haemodialysis (HD-patients) have an increased risk of premature death. Low levels of IgM antibodies against malondialdehyde (anti-MDA) are associated with increased risk of cardiovascular disease (CVD) with underlying potential mechanisms described. Here, we studied subclasses and isotyp...
Main Authors: | Shailesh Kumar Samal, Abdul Rashid Qureshi, Mizanur Rahman, Peter Stenvinkel, Johan Frostegård |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/3/753 |
Similar Items
-
Effect of hemodialysis fluid cooling uremic pruritus in hemodialysis patients
by: Tamadon Mohammad-Reza
Published: (2012-04-01) -
Haemodialysis Treatment Monitored On-line by Ultra Violet Absorbance
by: Uhlin, Fredrik
Published: (2006) -
Prevalence of diarrhea in end-stage renal disease patients initiating hemodialysis
by: Miho Oba, et al.
Published: (2021-07-01) -
Natural antibodies to malondialdehyde adducts in atherosclerosis
by: Turunen, P. (Pauliina)
Published: (2013) -
The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
by: Myrthe A. M. van Delft, et al.
Published: (2017-08-01)